Serena Williams' Super Bowl commercial for GLP-1s and the telehealth company Ro has been met with criticism online after it ...

Despite their huge popularity, GLP-1 injury lawsuits citing the drugs as a cause for a host of severe GI issues and even ...

Time for Ozempic to walk the plank? Top dietitians in Australia this week are waving a red flag about an unforeseen impact of ...

One researcher found patients on the weight loss drugs may not be getting enough essential vitamins and nutrients.

When comedian and content creator Aishwarya Mohanraj revealed in a recent YouTube video that she used Eli Lilly’s Mounjaro ...

The upcoming drugs CagriSema and retatrutide target multiple gut hormones and could cause twice as much weight loss than ...

Doctors, patients and researchers are at the very beginning of understanding how the new class of obesity drugs interact with ...

AstraZeneca is taking its oral GLP-1 drug into phase 3 on the back of a pair of midstage weight loss wins, despite remaining ...

Patients using GLP-1 agonists had a significantly lower hysterectomy rate over 2-year and 5-year follow-up. Women with ...

Downgrade Hims & Hers Health, Inc. to Hold as FDA scrutiny and Novo’s lawsuit threaten compounded GLP-1 revenue. Click for ...

The GLP-1 market is a massive opportunity in healthcare, and many companies are vying for a piece of it.

With the use of GLP-1 medications on the rise, cardiologists are seeing benefits to heart health, and it might not all be ...